The purpose of this document is to describe and explain how to apply the principles of good clinical practices (GCP) and good data management practices (GDMP) in the context of national tuberculosis (TB) surveys, namely national population-based surveys of TB prevalence, anti-TB drug resistance surveys, and surveys of costs faced by TB patients and their households. The primary target audience for this handbook includes national TB programmes (NTPs) and partners involved in the planning, design, conduct, oversight, analysis and reporting of a national TB survey. The in-country national survey coordination team is responsible for ensuring that all survey team members conform to this guidance document.

Rev. ed. of: Assessing tuberculosis prevalence through population-based surveys. 2007.

The emergence of extensively drug-resistant strains of tuberculosis, especially in countries with a high prevalence of human immunodeficiency virus, is a serious threat to global public health and jeopardizes efforts to effectively control the disease. This publication offers updated recommendations for the diagnosis and management of drug-resistant tuberculosis in a variety of geographical, economic and social settings, and the recording of data that enables the monitoring and evaluation of programs.--Publisher's description.

One of the global targets of WHO’s End TB Strategy is that no TB patients and their households face catastrophic costs as a result of TB disease. This book provides comprehensive documentation about 20 national surveys of costs faced by TB patients and their households that were completed between 2015 and 2021, according to WHO-recommended methods. Results include estimates of the proportion of TB patients and their households facing catastrophic costs, as well as a wealth of other data. It is hoped that the book will serve as a key reference for ministries of health and other government agencies, and their national and international partners, as they work towards reducing costs faced by TB patients and their households. The book was a collaborative effort of the 20 countries in which surveys were done and their technical partners, with contributions from more than 300 people.

The WHO consolidated guidelines on tuberculosis. Module 2: screening – systematic screening for tuberculosis disease is an updated and consolidated summary of WHO recommendations on systematic screening for tuberculosis (TB) disease, containing 17 recommendations for populations in which TB screening should be conducted and tools to be used for TB screening. TB screening is strongly recommendations for household and close contacts of individuals with TB, people living with HIV, miners exposed to silica dust, and prisoners. In addition, screening is conditionally recommended for people with risk factors for TB attending health care, and for communities with risk factors for TB and limited access to care (e.g. homeless, urban poor, refugees, migrants). General population screening is recommended in high-burden settings (0.5% prevalence or higher). Symptoms, chest radiography (CXR), and molecular WHO-recommended rapid diagnostic tests for TB are recommended as screening tools for all adults eligible for screening. Computer-aided detection programmes are recommended as alternatives to human interpretation of CXR in settings where trained personnel are scarce. For people living with HIV, C-reactive protein is also a good screening tool. This guideline document is accompanied by an operational handbook, the WHO operational handbook on tuberculosis. Module 2: screening – systematic screening for tuberculosis disease, that presents principles of screening, steps in planning and implementing a screening programme, and algorithm options for screening different populations.

These Guidelines represent the first attempt to provide international recommendations on collecting, publishing, and analysing subjective well-being data.